Last update 01 Nov 2024
Xingan Pharmaceutical Co. Ltd.
Last update 01 Nov 2024
Overview
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
预试验：依折麦布阿托伐他汀钙片（10mg/20mg）在健康受试者空腹和餐后状态下的随机、开放、单剂量、两制剂、两周期、两序列、交叉生物等效性预试验
正式试验：依折麦布阿托伐他汀钙片（10mg/20mg）在健康受试者空腹和餐后状态下的随机、开放、单剂量、两制剂、三周期、三序列、部分重复交叉生物等效性试验
[Translation] Preliminary study: Randomized, open, single-dose, two-formulation, two-period, two-sequence, crossover bioequivalence preliminarily study of ezetimibe atorvastatin calcium tablets (10mg/20mg) in healthy subjects in the fasting and postprandial state
Formal study: Randomized, open, single-dose, two-formulation, three-period, three-sequence, partially repeated crossover bioequivalence study of ezetimibe atorvastatin calcium tablets (10mg/20mg) in healthy subjects in the fasting and postprandial state
预试验：依折麦布阿托伐他汀钙片（10mg/10mg）在健康受试者空腹和餐后状态下的随机、开放、单剂量、两制剂、两周期、两序列、交叉生物等效性预试验
正式试验：依折麦布阿托伐他汀钙片（10mg/10mg）在健康受试者空腹和餐后状态下的随机、开放、单剂量、两制剂、三周期、三序列、部分重复交叉生物等效性试验
[Translation] Preliminary study: Randomized, open, single-dose, two-formulation, two-period, two-sequence, crossover bioequivalence preliminarily study of ezetimibe atorvastatin calcium tablets (10mg/10mg) in healthy subjects in the fasting and postprandial state
Formal study: Randomized, open, single-dose, two-formulation, three-period, three-sequence, partially repeated crossover bioequivalence study of ezetimibe atorvastatin calcium tablets (10mg/10mg) in healthy subjects in the fasting and postprandial state
健康受试者单次口服洛索洛芬钠片的随机、开放、二序列、二周期、双交叉，空腹和高脂餐后给药条件下的人体生物等效性试验
[Translation] A randomized, open-label, two-sequence, two-period, double-crossover bioequivalence study of a single oral dose of loxoprofen sodium tablets in healthy subjects under fasting and high-fat meal administration conditions
100 Clinical Results associated with Xingan Pharmaceutical Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Xingan Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Xingan Pharmaceutical Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 19 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free